Noerr advises IDT Biologika on raising a €165 million loan

Noerr has advised the pharmaceutical and biotechnology company IDT Biologika GmbH on a financing deal aimed at ensuring its continued growth. The Dessau-based company for the first time took up a comprehensive syndicated operating and investment loan (which includes the possibility of further acquisitions). The overall volume of the loan is €165 million.

The lending consortium of banks consists of Deutsche Bank AG, HSBC Trinkaus & Burkhardt, Commerzbank AG, NORD/LB, Bremer Kreditbank AG and UniCredit S.p.A., with Deutsche Bank AG and Commerzbank AG acting as lead banks.

For more than 95 years IDT has been concerned with products for the protection of human and animal health, particularly in the field of vaccines. The company, which is part of the KLOCKE GROUP, today has a workforce of 1,500. IDT was advised by a Noerr team of the Banking & Finance Group led by the Frankfurt partner Sebastian Bock.

Advisors to IDT Biologika GmbH: Noerr LLP

Sebastian Bock (lead), Dr. Torsten Wehrhahn, Associate: Hans-Christian Mick (all Banking & Finance, Noerr Frankfurt)